These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33548691)

  • 1. A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use.
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Psychiatry Res; 2021 Apr; 298():113760. PubMed ID: 33548691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of psychiatric symptoms exacerbated by methamphetamine use.
    McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
    Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hostility among methamphetamine users experiencing psychotic symptoms.
    McKetin R; McLaren J; Lubman DI; Hides L
    Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia.
    Wang LJ; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Chen CK
    Psychopathology; 2016; 49(2):108-15. PubMed ID: 27071042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.
    Zarrabi H; Khalkhali M; Hamidi A; Ahmadi R; Zavarmousavi M
    BMC Psychiatry; 2016 Feb; 16():44. PubMed ID: 26911516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
    McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI
    Psychiatry Res; 2016 Apr; 238():166-171. PubMed ID: 27086229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
    Shelly J; Uhlmann A; Sinclair H; Howells FM; Sibeko G; Wilson D; Stein DJ; Temmingh H
    Psychopathology; 2016; 49(6):429-435. PubMed ID: 27926911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?
    McKetin R; Voce A; Burns R; Ali R; Lubman DI; Baker AL; Castle DJ
    Front Psychiatry; 2018; 9():578. PubMed ID: 30524318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Voce A; McKetin R; Burns R; Castle D; Calabria B
    Psychiatry Res; 2018 Jul; 265():19-24. PubMed ID: 29680513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic symptoms in methamphetamine psychotic in-patients.
    Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
    Voce A; Calabria B; Burns R; Castle D; McKetin R
    Subst Use Misuse; 2019; 54(4):549-559. PubMed ID: 30693832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typologies of positive psychotic symptoms in methamphetamine dependence.
    Bousman CA; McKetin R; Burns R; Woods SP; Morgan EE; Atkinson JH; Everall IP; Grant I;
    Am J Addict; 2015 Mar; 24(2):94-97. PubMed ID: 25864598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 18. How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data.
    McKetin R; Clare PJ; Castle D; Turner A; Kelly PJ; Lubman DI; Arunogiri S; Manning V; Berk M
    Addiction; 2023 Oct; 118(10):1975-1983. PubMed ID: 37157055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
    Mahoney JJ; Hawkins RY; De La Garza R; Kalechstein AD; Newton TF
    Gend Med; 2010 Oct; 7(5):414-21. PubMed ID: 21056868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.